Contribution: Industrial Research Assistance Program – Contributions to Firms
Vital Biosciences Inc.
$369,000.00
Technology development for remote test quality assurance
FY 2023-24 · 2023-06-05
Summary
This project will cover the design and implementation of control systems to monitor the quality of reagents and various processes on our in vitro diagnostic platform. Having these systems in place will substantially mitigate the potential risk of patient harm by suppressing the results from any failed runs.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Mississauga|Mississauga, Ontario, Canada
Recipient Type
For-profit organization
Business Number
738751494
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-06-05 | 2023-24 | $285,000.00 |
| 1 | 2023-06-05 | 2023-24 | $369,000.00 |
| 3 | 2023-06-05 | 2023-24 | $369,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 61 jours.
Agreement End Date
2024-04-30
Agreement Number
1006751
Agreement Start Date
2023-06-05
Agreement Title
Technology development for remote test quality assurance
Agreement Title (French)
Développement de technologies pour l’assurance qualité des tests à distance
Agreement Type
Contribution
Agreement Value
$369,000.00
Amendment Date
2023-12-20
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will cover the design and implementation of control systems to monitor the quality of reagents and various processes on our in vitro diagnostic platform. Having these systems in place will substantially mitigate the potential risk of patient harm by suppressing the results from any failed runs.
Description (French)
Ce projet couvrira la conception et la mise en œuvre de systèmes de contrôle pour surveiller la qualité des réactifs et de divers processus sur notre plateforme de diagnostic in vitro. La mise en place de ces systèmes permettra d’atténuer considérablement le risque potentiel de préjudice pour les patients en supprimant les résultats de toute série d’essais non réussis.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Mississauga--Erin Mills
Federal Riding (French)
Mississauga--Erin Mills
Federal Riding Number
35060
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
738751494
Recipient City
Mississauga|Mississauga
Recipient Country
CA
Recipient Legal Name
Vital Biosciences Inc.
Recipient Postal Code
L5L 4L4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2023-2024-Q1-1006751
